91
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Quantifying the Immune Response to a Tissue-Engineered Porcine Extracellular Matrix

ORCID Icon, , , , , , , ORCID Icon, & ORCID Icon show all
Pages 229-237 | Received 29 Sep 2022, Accepted 06 Dec 2022, Published online: 24 Jan 2023

References

  • Nkomo VT , GardinJM , SkeltonTNet al. Burden of valvular heart diseases: a population-based study. Lancet368, 1005–1011 (2006).
  • Iung B , VahanianA. Epidemiology of acquired valvular heart disease. Can. J. Cardiol.30, 962–970 (2014).
  • Stewart BF , SiscovickD , LindBKet al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol.29, 630 (1997).
  • Nishimura RA , OttoCM , BonowROet al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J. Am. Coll. Cardiol.70, 252–289 (2017).
  • Bozso SJ , KangJJH , MathewAet al. Comparing scaffold design and recellularization techniques for development of tissue engineered heart valves. Regen. Eng. Transl. Med.7, 432–439 (2020).
  • Mrsic Z , HopkinsPS , AntevilLJet al. Valvular heart disease. Cardiovasc. Dis.45, 81–94 (2018).
  • Starr A , FesslerCL , GrunkemeierGet al. Heart valve replacement surgery: past, present and future. Clin. Exp. Pharmacol. Physiol.29, 735–738 (2002).
  • Bozso SJ , El-AndariR , Al-AdraDet al. A review of the immune response stimulated by xenogenic tissue heart valves. Scand. J. Immunol.93(4), e13018 (2020).
  • Bozso SSJ , KangJJH , BasuRet al. Structural valve deterioration is linked to increased immune infiltrate and chemokine expression. J. Cardiovasc. Transl. Res.14(3), 503–512 (2020).
  • Head SJ , ÇelikM , KappeteinAP. Mechanical versus bioprosthetic aortic valve replacement. Eur. Heart J.38, 2183–2191 (2017).
  • Cheung DY , DuanB , ButcherJT. Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions. Expert Opin. Biol. Ther.15, 1155–1172 (2015).
  • Vesely I . Heart valve tissue engineering. Circ. Res.97(8), 743–755 (2005).
  • Schenke-Layland K , VasilevskiO , OpitzFet al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol.143, 201–208 (2003).
  • Grauss RW , HazekampMG , OppenhuizenFet al. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur. J. Cardiothorac. Surg.27, 566–571 (2005).
  • Simon P , KasimirMT , SeebacherGet al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT® in pediatric patients. Eur. J. Cardiothorac. Surg.23, 1002–1006 (2003).
  • Bozso SJ , KangJJH , EL-AndariRet al. Recellularization of xenograft heart valves reduces the xenoreactive immune response in an in vivo rat model. Eur. J. Cardiothorac. Surg.61(2), 427–436 (2021).
  • Cebotari S . Clinical Application of tissue engineered human heart valves using autologous progenitor cells. Circulation114, I–137 (2006).
  • Kang JJ , BozsoSJ , BoeDEet al. Resveratrol attenuates stimulated T-cell activation and proliferation: potential therapy against cellular rejection in organ transplantation. Am. J. Clin. Exp. Immunol.9, 81–90 (2020).
  • Kang JJH , BozsoSJ , El-AndariRet al. Sternal bone marrow harvesting and culturing techniques from patients undergoing cardiac surgery. Micromachines12(8), 897 (2021).
  • Griffiths LG , ChoeLH , ReardonKFet al. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials29, 3514 (2008).
  • Gates K v , DalglieshAJ , GriffithsLG. Antigenicity of bovine pericardium determined by a novel immunoproteomic approach. Sci. Rep.7, 2410–2446 (2017).
  • Bozso SJ , KangJJH , EL‐AndariRet al. Recellularized bovine pericardium with autologous mesenchymal stem cells reduces immune activation. Xenotransplantation29(6), e12774 (2022).
  • Sutherland FWH , PerryTE , YuYet al. From stem cells to viable autologous semilunar heart valve. Circulation111, 2783–2791 (2005).
  • Vincentelli A , WautotF , JuthierFet al. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J. Thorac. Cardiovasc. Surg. 134, 424–432 (2007).
  • Aggarwal S , PittengerMF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood105, 1815–1822 (2005).
  • Li N , HuaJ. Interactions between mesenchymal stem cells and the immune system. Cell. Mol. Life Sci.74, 2345–2360 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.